Evidence map›Paper›PMID 35846906›Full record

ArticleClinical case reports2022

Friend or foe-The Pfizer-BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis.

Bianca Maria Wahlen, Ruben Peralta, Hassan Al-Thani, Ayman El-Menyar

Erratum issuedOpen access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Acute abdomen following COVID-19 vaccination: a systematic review.Clinical and experimental vaccine research · 2024
    Article
  2. Article
  3. Corrigendum.Clinical case reports · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Bianca Maria WahlenDepartment of Anesthesiology Hamad Medical Corporation (HMC) Doha Qatar.ORCID https://orcid.org/0000-0002-8218-2375
Ruben PeraltaDepartment of Surgery, Trauma Surgery Hamad Medical Corporation (HMC) Doha Qatar.
Hassan Al-ThaniDepartment of Surgery, Trauma and Vascular Surgery Hamad Medical Corporation (HMC) Doha Qatar.
Ayman El-MenyarDepartment of Surgery, Trauma and Vascular Surgery Clinical Research Hamad Medical Corporation (HMC) Doha Qatar.ORCID https://orcid.org/0000-0003-2584-953X
Hamad Medical Corporation · QAUniversidad Nacional Pedro Henríquez Ureña · DOWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We described a rare case of vaccine-induced acalculous cholecystitis (ACC). A 52-year-old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer-BioNTech COVID-19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and laboratory findings went back to normal.

Indexed as

acalculous cholecystitisadverse eventboosterCOVID‐19 vaccination

Identifiers

PMID35846906
PMCPMC9280744
OpenAlexW4285405137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.